Volume 28, Number 12—December 2022
Synopsis
Systematic Review and Meta-analysis of Lyme Disease Data and Seropositivity for Borrelia burgdorferi, China, 2005‒2020
Table 2
Distribution of estimates of seropositivity for Borrelia burgdorferi sensu lato, by exposure group and province, China, 2005–2020
Province | Total no. estimates, n = 72 | Clinical suspicion estimates, n = 10 | Exposure group |
||
---|---|---|---|---|---|
Low risk, n = 10 | Moderate risk, n = 12 | High risk, n = 40 | |||
Beijing | 6 | 2 | 1 | 1 | 2 |
Fujian | 2 | 0 | 1 | 0 | 1 |
Gansu | 4 | 0 | 0 | 0 | 4 |
Guangdong | 2 | 0 | 0 | 1 | 1 |
Guizhou | 3 | 0 | 1 | 1 | 1 |
Hainan | 4 | 4 | 0 | 0 | 0 |
Heilongjiang | 3 | 2 | 0 | 0 | 1 |
Henan | 2 | 0 | 0 | 0 | 2 |
Hunan | 2 | 0 | 0 | 0 | 2 |
Jilin | 7 | 0 | 1 | 1 | 5 |
Neimenggu | 4 | 1 | 1 | 0 | 2 |
Ningxia | 1 | 0 | 0 | 0 | 1 |
Qinghai | 2 | 0 | 0 | 0 | 2 |
Shaanxi | 1 | 0 | 0 | 0 | 1 |
Shandong | 1 | 0 | 0 | 0 | 1 |
Shanxi | 2 | 0 | 0 | 0 | 2 |
Tianjin | 2 | 0 | 1 | 0 | 1 |
Xinjiang | 18 | 0 | 2 | 8 | 8 |
Yunnan | 1 | 0 | 1 | 0 | 0 |
Zhejiang | 5 | 1 | 1 | 0 | 3 |
Page created: November 01, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.